Boryung Pharm (003850) — Cash Flow Quality Index
Boryung Pharm (003850) has a Cash Flow Quality Index of 1.44x as of September 2025. Operating cash flow of ₩48.95 Billion exceeds net income of ₩34.00 Billion, indicating high earnings quality where cash backs reported profits. Explore Boryung Pharm long-term investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Boryung Pharm Cash Flow Quality Index (2009–2024)
Historical Cash Flow Quality Index for Boryung Pharm across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Boryung Pharm tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Boryung Pharm (2009–2024)
Year-by-year earnings quality comparison for Boryung Pharm. For live market cap and the full company financial profile, see Boryung Pharm (003850) total market value.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.11x | ₩80.56 Billion | ₩72.77 Billion | ▲ +5.4% |
| 2023 | 1.05x | ₩42.22 Billion | ₩40.20 Billion | ▲ +54.5% |
| 2022 | 0.68x | ₩27.81 Billion | ₩40.92 Billion | ▼ -51.4% |
| 2021 | 1.40x | ₩60.17 Billion | ₩43.04 Billion | ▼ -16.1% |
| 2020 | 1.67x | ₩44.74 Billion | ₩26.86 Billion | ▲ +14.2% |
| 2019 | 1.46x | ₩47.00 Billion | ₩32.22 Billion | ▼ -23.9% |
| 2018 | 1.92x | ₩38.91 Billion | ₩20.31 Billion | ▲ +541.4% |
| 2017 | -0.43x | ₩-24.61 Billion | ₩56.70 Billion | ▼ -126.0% |
| 2016 | 1.67x | ₩9.36 Billion | ₩5.61 Billion | ▼ -14.7% |
| 2012 | 1.95x | ₩18.38 Billion | ₩9.40 Billion | ▲ +31.5% |
| 2011 | 1.49x | ₩9.19 Billion | ₩6.18 Billion | ▼ -11.5% |
| 2010 | 1.68x | ₩24.12 Billion | ₩14.35 Billion | ▲ +142.4% |
| 2009 | 0.69x | ₩3.59 Billion | ₩5.18 Billion | — |